By Colin Kellaher

Shares of Surgalign Holdings Inc. jumped more than 20% in premarket trading Tuesday after the medical-technology company received U.S. Food & Drug Administration approval for use of its HOLO Portal surgical-guidance system within lumbar- spine procedures.

The Deerfield, Ill., company said the approval makes the HOLO Portal system the world's first artificial intelligence-driven augmented-reality guidance system for the spine and marks the first clinical application of its HOLO AI digital health platform.

Surgalign shares, which closed Friday at 84.6 cents, were recently up 21.8% to $1.03 in premarket trading.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

January 18, 2022 08:12 ET (13:12 GMT)

Surgalign (NASDAQ:SRGA)
Historical Stock Chart
From Apr 2022 to May 2022

Surgalign (NASDAQ:SRGA)
Historical Stock Chart
From May 2021 to May 2022